{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:25:54Z","timestamp":1791116754645,"version":"4.1.0"},"reference-count":25,"publisher":"ALUNA","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wiad Lek"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:p>The aim: Identify differences in indexes of body fat and muscle masses, as well as blood adipokines in patients with nonalcoholic fatty liver disease, from gender-appropriate healthy men and women. \nMaterials and methods: 135 patients with non-alcoholic fatty liver disease with normal, overweight and obesity and 20 almost healthy individuals for the control group were examined. Verification of the diagnosis was performed in accordance with the recommendations of the unified clinical protocol. An anthropometric examination of patients was performed according to the method, which included the determination of 48 anthropometric parameters. The formulas determined the absolute amount of adipose and muscle tissue. Levels of adipokines (leptin and adiponectin) were determined by enzyme-linked immunosorbent assay. \nResults: According to Matiegka, body fat was 30.2-35.2% higher, and muscle body weight was 17.4-29.1% lower in patients with non-alcoholic fatty liver disease compared to healthy people. The concentration of leptin in the serum of patients with nonalcoholic fatty liver disease was statistically significantly higher (2.05-3.78 times) compared with almost healthy individuals. At the same time, the indicators of adiponectin concentration (1.54-1.92 times) and log A \/ L index (1.16-1.32 times) were lower. Correlations between changes in muscle mass and adipokines concentration have been established. \nConclusions: In addition to the known increase in body fat in non-alcoholic fatty liver disease, there has been established a significant decrease in muscle mass. A direct correlation between adiponectin concentration and an inverse correlation between leptin levels and muscle mass in patients with nonalcoholic fatty liver disease was found.<\/jats:p>","DOI":"10.36740\/wlek202205210","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T15:37:22Z","timestamp":1656344242000},"page":"1289-1294","source":"Crossref","is-referenced-by-count":7,"title":["FAT AND MUSCLE COMPONENTS OF BODY WEIGHT AND THEIR RELATIONSHIP WITH THE CONCENTRATION OF SERUM ADIPOKINES IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE"],"prefix":"10.36740","volume":"75","author":[{"given":"Kateryna","family":"Pivtorak","sequence":"first","affiliation":[{"name":"NATIONAL PIROGOV MEMORIAL MEDICAL UNIVERSITY, VINNYTSIA, UKRAINE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iryna","family":"Fedzhaga","sequence":"additional","affiliation":[{"name":"NATIONAL PIROGOV MEMORIAL MEDICAL UNIVERSITY, VINNYTSIA, UKRAINE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalya","family":"Pivtorak","sequence":"additional","affiliation":[{"name":"NATIONAL PIROGOV MEMORIAL MEDICAL UNIVERSITY, VINNYTSIA, UKRAINE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larysa","family":"Vozniuk","sequence":"additional","affiliation":[{"name":"NATIONAL PIROGOV MEMORIAL MEDICAL UNIVERSITY, VINNYTSIA, UKRAINE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olexandra","family":"Klekot","sequence":"additional","affiliation":[{"name":"NATIONAL PIROGOV MEMORIAL MEDICAL UNIVERSITY, VINNYTSIA, UKRAINE"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22436","published-online":{"date-parts":[[2022]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Loomis A.K., Kabadi S., Preiss D. et al. Body mass index and risk of nonalcoholic fatty liver disease: two electronic health record prospective studies. The Journal of Clinical Endocrinology & Metabolism. 2016;101(3): 945-952.","DOI":"10.1210\/jc.2015-3444"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Buzzetti E., Pinzani M., Tsochatzis E.A. The multiple-hit pathogenesis of nonalcoholic fatty liver disease (NAFLD) Metabolism. 2016;65:1038\u2013 1048.","DOI":"10.1016\/j.metabol.2015.12.012"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Kim K.M., Jang H.C., Lim S. Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia. The Korean journal of internal medicine. 2016;31(4): 643.","DOI":"10.3904\/kjim.2016.015"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Gan D., Wang L., Jia M. et al. Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease. Clin Nutr 2020;39(4):1124\u20131130.","DOI":"10.1016\/j.clnu.2019.04.023"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Kitajima Y., Hyogo H., Sumida Y. et al. Severity of non-alcoholic steatohepatitis is associated with substitution of adipose tissue in skeletal muscle. J Gastroenterol Hepatol. 2013;28(9):1507\u20131514.","DOI":"10.1111\/jgh.12227"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Nachit M., Leclercq I.A. Emerging awareness on the importance of skeletal muscle in liver diseases: time to dig deeper into mechanisms! Clin Sci. 2019;133(3):465\u2013481.","DOI":"10.1042\/cs20180421"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Tanaka M., Okada H., Hashimoto Y. et al. Relationship between nonalcoholic fatty liver disease and muscle quality as well as quantity evaluated by computed tomography. Liver Int. 2020;40(1):120\u2013130.","DOI":"10.1111\/liv.14253"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Nachit M., Kwanten W.J., Thissen J.P. et al. Muscle fat content is strongly associated with NASH: a longitudinal study in patients with morbid obesity. Journal of hepatology. 2021; 75: 292\u2013301.","DOI":"10.1016\/j.jhep.2021.02.037"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. De Fr\u00e9 C.H., De Fr\u00e9 M.A., Kwanten W.J. et al. Sarcopenia in patients with non-alcoholic fatty liver disease: is it a clinically significant entity? Obes Rev. 2019;20:353\u2013363.","DOI":"10.1111\/obr.12776"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Wijarnpreecha K., Kim D., Raymond P. et al. Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA. Eur J Gastroenterol Hepatol. 2019;31:1121\u20131128.","DOI":"10.1097\/meg.0000000000001397"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Chung G.E., Kim M.J., Yim J.Y. et al. Sarcopenia is significantly associated with presence and severity of nonalcoholic fatty liver disease. J Obes Metab Syndr. 2019;28:129\u2013138.","DOI":"10.7570\/jomes20046"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Golabi P., Gerber L., Paik J.M. et al. Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease. JHEP Reports, 2020;2(6): 100171.","DOI":"10.1016\/j.jhepr.2020.100171"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"13. Kim T., Choi K. Sarcopenia. Definition, epidemiology, and pathophysiology. J Bone Metab. 2013; 20:1\u201310.","DOI":"10.11005\/jbm.2013.20.1.1"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Krause M.P., Milne K.J., Hawke T.J. Adiponectin \u2014 Consideration for its role in skeletal muscle health. International journal of molecular sciences. 2019; 20(7):1528.","DOI":"10.3390\/ijms20071528"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Santos A.R., Zanuso B.D., Miola V.F. et al. Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions. International Journal of Molecular Sciences. 2021; 22(5): 2639.","DOI":"10.3390\/ijms22052639"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Divella R., Mazzocca A., Daniele A. et al. Obesity, nonalcoholic fatty liver disease and adipocytokines network in promotion of cancer. International journal of biological sciences. 2019; 15(3):610.","DOI":"10.7150\/ijbs.29599"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Adolph T.E., Grander C., Grabherr F. et al. Adipokines and non-alcoholic fatty liver disease: multiple interactions. International journal of molecular sciences. 2017; 18(8):1649.","DOI":"10.3390\/ijms18081649"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Mart\u00ednez-U\u00f1a M., L\u00f3pez-Manche\u00f1o Y., Di\u00e9guez C. et al. Unraveling the Role of Leptin in Liver Function and Its Relationship with Liver Diseases. International Journal of Molecular Sciences. 2020; 21(24):9368.","DOI":"10.3390\/ijms21249368"},{"key":"ref18","unstructured":"19. Chtetsov V.P., Negasheva M.A., Lapshina N.E. Izuchenie sostava tela u vzroslogo naseleniya: metodicheskie aspektyi. Vestnik Moskovskogo universiteta. Seriya 23. Antropologiya. 2012;(2):43-52. (in Russian)."},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Ze Chen, Rong-Quan Fu. The association between sarcopenia and non-alcoholic fatty liver disease. Journal of Hepatology. 2017; 66(1):243-244.","DOI":"10.1016\/j.jhep.2016.09.023"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Koo B.K., Kim D., Joo S.K. et al. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. Journal of Hepatology. 2017; 66 (1): 123-131.","DOI":"10.1016\/j.jhep.2016.08.019"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Pivtorak K.V., Shevchuk N.A., Pivtorak N.A. et al. Correction of adipocyte secretion disorders in patients with non-alcoholic fatty liver disease with overweight and obesity. Wiad Lek. 2019;72(8):1477-1480.","DOI":"10.36740\/wlek201908111"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Piette A.B., Hamoudi D., Marcadet L. et al. Targeting the muscle-bone unit: filling two needs with one deed in the treatment of Duchenne muscular dystrophy. Current osteoporosis reports. 2018; 16(5): 541-553.","DOI":"10.1007\/s11914-018-0468-2"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Davuluri G., Krokowski D., Guan B.J. et al. Metabolic adaptation of skeletal muscle to hyperammonemia drives the beneficial effects of l-leucine in cirrhosis. Journal of hepatology. 2016;65(5):929-937.","DOI":"10.1016\/j.jhep.2016.06.004"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Bhanji R.A., Narayanan P., Allen A.M. et al. Sarcopenia in hiding: the risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis. Hepatology. 2017;66(6):2055-2065.","DOI":"10.1002\/hep.29420"}],"container-title":["Wiadomo\u015bci Lekarskie"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T15:37:28Z","timestamp":1656344248000},"score":1,"resource":{"primary":{"URL":"https:\/\/wiadlek.pl\/wp-content\/uploads\/archive\/2022\/05\/WLek202205210.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022]]},"published-print":{"date-parts":[[2022,5]]}},"URL":"https:\/\/doi.org\/10.36740\/wlek202205210","archive":["Internet Archive"],"relation":{},"ISSN":["0043-5147"],"issn-type":[{"value":"0043-5147","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}